These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12454753)

  • 1. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation.
    Tedeschi A; Cairoli R; Marenco P; Nosari A; Tresoldi E; Di Bona E; Montillo M; Morra E
    Leukemia; 2002 Dec; 16(12):2455-6. PubMed ID: 12454753
    [No Abstract]   [Full Text] [Related]  

  • 2. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.
    Leoni F; Gianfaldoni G; Annunziata M; Fanci R; Ciolli S; Nozzoli C; Ferrara F
    Haematologica; 2002 May; 87(5):485-9. PubMed ID: 12010661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy.
    Kai T; Kimura H; Shiga Y; Ogawa K; Sato H; Maruyama Y
    Int J Hematol; 2006 May; 83(4):337-40. PubMed ID: 16757435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
    Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
    Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide].
    Iguchi T; Yokoyama K; Miyamoto K; Aisa Y; Shimizu T; Mori T; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Jan; 45(1):75-7. PubMed ID: 14999939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
    Soignet SL; Maslak P; Wang ZG; Jhanwar S; Calleja E; Dardashti LJ; Corso D; DeBlasio A; Gabrilove J; Scheinberg DA; Pandolfi PP; Warrell RP
    N Engl J Med; 1998 Nov; 339(19):1341-8. PubMed ID: 9801394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.
    Grigg A; Kimber R; Szer J
    Leukemia; 2003 Sep; 17(9):1916-7; author reply 1918. PubMed ID: 12970801
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients.
    Au WY; Li CK; Lee V; Yuen HL; Yau J; Chan GC; Ha SY; Kwong YL
    Pediatr Blood Cancer; 2012 Apr; 58(4):630-2. PubMed ID: 21898784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia.
    Galimberti S; Papineschi F; Carmignani A; Testi R; Fazzi R; Petrini M
    Bone Marrow Transplant; 1999 Aug; 24(3):345-8. PubMed ID: 10455379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
    Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
    Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
    [No Abstract]   [Full Text] [Related]  

  • 14. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.
    Carmosino I; Latagliata R; Avvisati G; Breccia M; Finolezzi E; Lo Coco F; Petti MC
    Haematologica; 2004 May; 89(5):615-7. PubMed ID: 15136230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.
    Shigeno K; Naito K; Sahara N; Kobayashi M; Nakamura S; Fujisawa S; Shinjo K; Takeshita A; Ohno R; Ohnishi K
    Int J Hematol; 2005 Oct; 82(3):224-9. PubMed ID: 16207595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
    Lazo G; Kantarjian H; Estey E; Thomas D; O'Brien S; Cortes J
    Cancer; 2003 May; 97(9):2218-24. PubMed ID: 12712474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of relapsed acute promyelocytic leukemia in a patient receiving continuous ambulatory peritoneal dialysis with oral arsenic trioxide.
    Au WY; Cheung GT; Yuen TW; Kumana CR; Kwong YL
    Arch Intern Med; 2005 May; 165(9):1067-8. PubMed ID: 15883249
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure.
    Au WY; Liu CL; Tam S; Fong BM; Shek TW; Hui CK; Kwong YL
    Ann Hematol; 2007 Oct; 86(10):771-2. PubMed ID: 17571262
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular remission with arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia.
    George B; Mathews L; Balasubramanian P; Shaji RV; Srivastava A; Chandy M
    Haematologica; 2004 Oct; 89(10):1266-7. PubMed ID: 15477216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.